首页|八珍汤联合EPO治疗乳腺癌肿瘤化疗相关性贫血的疗效及对血清炎症因子的影响

八珍汤联合EPO治疗乳腺癌肿瘤化疗相关性贫血的疗效及对血清炎症因子的影响

扫码查看
目的 研究八珍汤联合人重组促红素(EPO)用于乳腺癌患者肿瘤化疗相关贫血的治疗效果,并观察对患者炎性因子水平的影响.方法 选取2023年1月至2024年1月启东市人民医院收治的82例乳腺癌化疗相关性贫血患者,根据治疗方案不同分为观察组(n=42,行八珍汤联合EPO治疗)和对照组(n=40,行EPO治疗).记录两组治疗效果和不良反应发生率,比较两组干预前后免疫功能(CD3+、CD4+、CD8+及CD4+/CD8+)和炎性因子[C反应蛋白(CRP)和白介素⁃6(IL⁃6)]水平.结果 治疗后两组血清白蛋白(Alb)、血清前白蛋白(PA)及血红蛋白(Hb)均高于治疗前,且治疗后观察组Alb、PA及Hb高于对照组,差异有统计学意义(P<0.05).两组不良反应发生率比较差异无统计意义(P>0.05).治疗后观察组CD3+、CD4+及CD4+/CD8+显著高于对照组,CD8+显著低于对照组,差异均有统计学意义(P<0.05).两组治疗后血清CRP和IL⁃6均低于治疗前,且治疗后观察组血清CRP和血清IL⁃6低于对照组,差异有统计学意义(P<0.05).结论 八珍汤联合EPO治疗乳腺癌患者肿瘤化疗相关性贫血效果显著,有助于纠正贫血,抑制炎症因子水平,增强机体免疫功能.
Effect of Bazhen decoction combined with EPO on tumor chemotherapy related anemia in breast cancer patients and its influence on serum inflammatory factors
Objective To study the therapeutic effect of Bazhen Decoction combined with erythro⁃poietin(EPO)on tumor chemotherapy related anemia in patients with breast cancer and observe the effect on the level of inflammatory factors.Methods 82 patients with chemotherapy related anemia of breast cancer were admitted to Qidong People's Hospital from January 2023 to January 2024 were selected.They were divided into an observation group(n=42,treated with Bazhen Decoction combined with EPO intervention)and a con⁃trol group(n=40,treated with EPO intervention),based on different treatment plans.The treatment effects and incidence of adverse reactions in two groups were recorded,The levels of immune function[CD3+,CD4+,CD8+,and CD4+/CD8+]and inflammatory factors[C⁃reactive protein(CRP)and interleukin⁃6(IL⁃6)]between the two groups before and after intervention were compared.Results After treatment,the levels of serum albu⁃min(Alb),serum prealbumin(PA),and hemoglobin(Hb)in both groups were higher than before treatment,and the observation group had higher levels of Alb,PA,and Hb than those of control group,the difference were statistically significant(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).After treatment,the CD3+,CD4+,and CD4+/CD8+levels in the observation group were significantly higher than those in the control group,and the CD8+levels were significantly lower than those in the control group,the differences were statistically significant(P<0.05).After treatment,the serum CRP and IL⁃6 levels in the two groups of patients were lower than before treatment,and the serum CRP and IL⁃6 levels in the observation group were lower than those in the control group,the difference were statistically significant(P<0.05).Conclusion Bazhen Decoction combined with EPO has a significant effect on tumor che⁃motherapy related anemia in breast cancer patients.This combination is helpful in correcting anemia,inhibiting the levels of inflammatory factors,and enhancing the immune function of the body.

Bazhen DecoctionErythropoietinBreast cancerChemotherapy associated anemia

郭雪美、倪冲、季沈杰、顾卫卫

展开 >

启东市人民医院/启东肝癌防治研究所/南通大学附属启东医院药剂科,江苏,启东 226200

启东市人民医院/启东肝癌防治研究所/南通大学附属启东医院检验科,江苏,启东 226200

八珍汤 人重组促红素 乳腺癌 化疗相关性贫血

江苏省医院协会南通市卫生健康委员会

JSYGY?3?2020?315QNZ2022087

2024

分子诊断与治疗杂志
中山大学

分子诊断与治疗杂志

CSTPCD
影响因子:0.65
ISSN:1674-6929
年,卷(期):2024.16(10)